Unaudited Condensed Statements of Operations - USD ($)		1 Months Ended	3 Months Ended		8 Months Ended	9 Months Ended
		Jan. 23, 2018	Sep. 30, 2019	Sep. 30, 2018	Sep. 30, 2018	Sep. 30, 2019
Operating expenses
Research and development			$ 2,563,528	$ 140,167	$ 759,355	$ 5,554,046
General and administrative			300,640	465,919	2,243,788	1,721,691
Total operating expenses			2,864,168	606,086	3,003,143	7,275,737
Loss from operations			(2,864,168)	(606,086)	(3,003,143)	(7,275,737)
Other income
Interest income			25,865	20,871	33,268	67,699
Total other income			25,865	20,871	33,268	67,699
Net loss			(2,838,303)	(585,215)	(2,969,875)	(7,208,038)
Preferred stock dividend			(258,635)	(219,498)	(505,516)	(768,876)
Net loss applicable to common stock			$ (3,096,938)	$ (804,713)	$ (3,475,391)	$ (7,976,914)
Net loss applicable to common stock per share, basic and diluted			$ (0.7)	$ (0.18)	$ (0.79)	$ (1.81)
Weighted average common shares outstanding, basic and diluted			4,400,000	4,400,000	4,400,000	4,400,000
Predecessor [Member]
Operating expenses
Research and development	[1]
General and administrative	[1]
Total operating expenses	[1]
Loss from operations	[1]
Other income
Interest income	[1]
Total other income	[1]
Net loss	[1]
Preferred stock dividend	[1]
Net loss applicable to common stock	[1]
Net loss applicable to common stock per share, basic and diluted
Weighted average common shares outstanding, basic and diluted

[1] On an as-converted basis.